News

Impel NeuroPharma will study the safety and tolerability of dihydroergotamine delivered through the company’s Precision Olfactory Delivery device.

Evidence determines that those receiving treatment for nAMD should delay cataract surgery within 6 months of starting treatment, if possible.

HIV-positive patients who take antiretroviral therapy have a lower risk of cancer than HIV-positive patients who are not taking antiretroviral drugs.

The system’s algorithm predicts glucose levels 30 minutes in advance and adjusts insulin delivery to reduce hypoglycemic events.

NOCDURNA is the first and only sublingual tablet indicated for treatment of nocturia due to nocturnal polyuria in adults awakening at least 2 times per night to urinate.

hATTR compass program will empower people with accurate genetic information so they can make informed decisions about their healthcare.

The Eversense CGM System sensor is implanted into the patient’s arm and sends glucose data every 5 minutes to a mobile app.

Researchers identified 6 types of potentially inappropriate prescriptions, all of which were associated with higher hazards for all-cause mortality, 4 with non-fatal overdose, and 5 with fatal overdose.

The FDA has approved a label expansion for C1 esterase inhibitor [human] (CINRYZE) as a preventative measure for pediatric angioedema attacks in children aged 6 years and older with hereditary angioedema (HAE).

Nicholas J Robert, MD, discusses treatment challenges associated with rare cancers like Merkel cell carcinoma.

This is the first and only therapy indicated in the US to help prevent angioedema attacks in pediatric patients as young as 6 years old.

Researchers noted that a reduction in the frequency of medication regimen has been proven to also aid treatment adherence.

Patients with a co-infection of Clostridium difficile and ulcerative colitis or Crohn’s disease have higher rates of in-hospital mortality and health care resource utilization.

Students battle stigma, uncertainty, and hurricanes to return home with an MD. But is it as bad as advertised?

The results suggest that this approach could streamline the diagnosis of diabetes, losing the need for the same elevated test needing to be repeated in a new blood sample.

Researchers found nonfatal opioid overdose survivors have a 20-fold greater mortality rate in the months following their incident. However, designated therapies for such patients have been proven to counter that risk.

Updated 24-week data was released from patients treated with the 900 mg dose of voxelotor in the ongoing HOPE-KIDS 1 Study, a phase 2a open-label study in adolescents ages 6 to 17 years with sickle cell disease (SCD).

Clinical data demonstrate that CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina.

The first patient is anticipated to be enrolled in the third quarter of 2018, and topline results will be expected by the beginning of 2020.

Updated interim data from Affimed NV’s phase 1b dose-escalation study evaluating AFM13 for the treatment of relapsed/refractory Hodgkin Lymphoma were released at the 23rd Congress of the European Hematology Association.

The condition is characterized by a display of persistent or recurrent gaming behavior, online or offline, and can appear in continuous, episodic, and recurrent patterns.

The Qualified Infections Disease Product (QIDP) designation gives ACX-362E access to incentives including Priority Review and eligibility for Fast track status.

This minimally invasive procedure provides additional options for the patient population suffering with sacral insufficiency fractures.

New immigration policies are affecting the health of thousands of migrant children, and physicians want the world to know about it.

The triad of companies said that, while the details have yet to be hammered out, the initiative will be long-term and “free from profit-making incentives and constraints.”

Alexion Pharmaceuticals, Inc. has submitted a BLA to the FDA for approval of ALXN1210 for the treatment of patients with paroxysmal nocturnal hemoglobinuria.

The medical group’s primary care offices managed to reduce wasted patient minutes by 7.6% through efforts to streamline and shore up patient throughput.

Many antimicrobials prescribed after Clostridium difficile infection are prescribed inappropriately.

An interactive parent-child therapy appears to reduce depression in children 3-6 years old. Interestingly, the therapy also improved symptoms of clinical depression in participating parents.

New data from the FUTURE 5 study show that the interleukin-17A antagonist slows the progression of joint structural damage compared to placebo.